Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
March 18, 2019 Off

Clinipace Selects TransPerfect’s Trial Interactive E-Feasibility and eTMF Solutions to Support Future Studies

By BusinessWire

NEW YORK–(BUSINESS WIRE)–TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for…

March 18, 2019 Off

California Life Sciences Association (CLSA) Appoints Andrew Setikas as Senior Vice President of Business Development and Strategy

By BusinessWire

Life Sciences Industry Leader Andrew Setikas to Take the Helm of CLSA’s Business Development, Membership and Strategic Alliance Activities SAN…

March 18, 2019 Off

Fractyl Expands Management Team as Company Initiates U.S. Clinical Trial in Type 2 Diabetes

By BusinessWire

LEXINGTON, Mass.–(BUSINESS WIRE)–Fractyl Laboratories Inc. (Fractyl) today announced the hiring of Margaret Borys as Chief Commercial Officer (CCO) and Juan…

March 18, 2019 Off

vTv Therapeutics Announces $15 Million of Class A Common Stock Financings

By BusinessWire

Proceeds Will Fund Start-Up Activities for Current and Future Clinical Trials HIGH POINT, N.C.–(BUSINESS WIRE)–vTv Therapeutics Inc. (Nasdaq:VTVT) (the “Company”)…

March 18, 2019 Off

Puma Biotechnology’s Licensing Partner Specialised Therapeutics Asia Receives Regulatory Approval to Commercialize NERLYNX® (neratinib) for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer

By BusinessWire

Neratinib becomes the first anti-HER2 treatment to be approved in Australia, as extended adjuvant therapy for early stage HER2-positive breast…

March 18, 2019 Off

Bicycle Therapeutics Appoints Pierre Legault as New Director and Board Chairman

By BusinessWire

CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic…

March 18, 2019 Off

Ono Pharmaceutical and twoXAR Announce Drug Discovery Research Collaboration

By BusinessWire

OSAKA, Japan & MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/ai?src=hash" target="_blank"gt;#ailt;/agt;–Ono Pharmaceutical Co., Ltd., a Japanese pharmaceutical research and development company, and…

March 18, 2019 Off

ArunA Bio Appoints Al Medwar as Executive Vice President, Corporate and Commercial Development

By BusinessWire

ATHENS, Ga–(BUSINESS WIRE)–ArunA Bio, a leader in the development of exosomes and exosome therapeutics for the treatment of neurodegenerative disorders,…

March 18, 2019 Off

Takeda Receives U.S. FDA Approval to Manufacture FLEXBUMIN® at New Plasma Manufacturing Facility near Covington, Georgia

By BusinessWire

FLEXBUMIN 25% [Albumin (Human)], USP, 25% Solution is indicated for hypovolemia, hypoalbuminemia, (burns, Adult Respiratory Distress Syndrome (ARDS), and nephrosis),…

March 18, 2019 Off

U.S. FDA Accepts BLA Filing of Aimmune Therapeutics’ AR101 for Peanut AllergyA

By BusinessWire

— If Approved, AR101 Will Be the First Medicine for This Life-Threatening Condition — BRISBANE, Calif.–(BUSINESS WIRE)–Aimmune Therapeutics, Inc. (Nasdaq:…

Posts pagination

Previous 1 … 3,350 3,351 3,352 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine